A carregar...
Update on the pharmacotherapy of cerebellar and central vestibular disorders
An overview of the current pharmacotherapy of central vestibular syndromes and the most common forms of central nystagmus as well as cerebellar disorders is given. 4-aminopyridine (4-AP) is recommended for the treatment of downbeat nystagmus, a frequent form of acquired persisting fixation nystagmus...
Na minha lista:
| Publicado no: | J Neurol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833819/ https://ncbi.nlm.nih.gov/pubmed/27083881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-015-7987-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|